Table 3 Comparison between the proposed method and the advanced method
Datasets | Papers | Year | Features | Acc |
|---|---|---|---|---|
DLBCL | Agarwalla et al. [32] | 2018 | 15 | 0.900 |
DLBCL | Medjahed et al. [33] | 2017 | 15 | 0.894 |
DLBCL | Wang et al. [34] | 2017 | 15 | 0.809 |
DLBCL | Apolloni et al. [35] | 2016 | 15 | 0.929 |
DLBCL | Wang et al. [36] | 2015 | 15 | 0.936 |
DLBCL | Maulik et al. [37] | 2013 | 15 | 0.918 |
DLBCL | Yu et al. [31] | 2021 | 15 | 0.946 |
DLBCL | Ours | 2022 | 1 | 0.975 |
Leukemia | Lu et al. [38] | 2019 | 9 | 0.952 |
Leukemia | Sun et al. [39] | 2018 | 3 | 0.927 |
Leukemia | Wang et al. [34] | 2017 | 8.3 | 0.961 |
Leukemia | Tumuluru et al. [40] | 2017 | / | 0.946 |
Leukemia | Ours | 2022 | 2 | 0.971 |
Prostate | Samson et al. [41] | 2021 | 3 | 0.830 |
Prostate | Khani et al. [42] | 2020 | 5 | 0.922 |
Prostate | Musheer et al. [43] | 2019 | 4 | 0.763 |
Prostate | Theera et al. [44] | 2018 | 5 | 0.874 |
Prostate | Paredes et al. [45] | 2017 | 24.32 | 0.928 |
Prostate | Gunavathi et al. [46] | 2014 | 10 | 0.927 |
Prostate | Ours | 2022 | 5 | 0.931 |